• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance.

作者信息

Houston J B

机构信息

Department of Pharmacy, University of Manchester, U.K.

出版信息

Biochem Pharmacol. 1994 Apr 29;47(9):1469-79. doi: 10.1016/0006-2952(94)90520-7.

DOI:10.1016/0006-2952(94)90520-7
PMID:8185657
Abstract
摘要

相似文献

1
Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance.体外药物代谢数据在预测体内代谢清除率方面的效用。
Biochem Pharmacol. 1994 Apr 29;47(9):1469-79. doi: 10.1016/0006-2952(94)90520-7.
2
Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data.根据体外代谢数据预测人体肝脏中的体内药物代谢。
Pharmacol Ther. 1997;73(2):147-71. doi: 10.1016/s0163-7258(96)00184-2.
3
Predictions of the in vivo clearance of drugs from rate of loss using human liver microsomes for phase I and phase II biotransformations.利用人肝微粒体进行I期和II期生物转化，根据损失速率预测药物的体内清除率。
Pharm Res. 2006 Apr;23(4):654-62. doi: 10.1007/s11095-006-9663-4. Epub 2006 Mar 24.
4
[In vivo activity of drug-metabolizing enzymes in various pathological conditions].[各种病理状况下药物代谢酶的体内活性]
Vopr Med Khim. 1985 Jan-Feb;31(1):76-9.
5
Metabolism of formaldehyde during in vitro drug demethylation.体外药物去甲基化过程中甲醛的代谢
Biochem Pharmacol. 1980 Jul 15;29(14):2023-9. doi: 10.1016/0006-2952(80)90487-6.
6
[Advances and related issues in the use of in vitro methods to predict metabolic clearance rate of new drugs].[体外方法预测新药代谢清除率的研究进展及相关问题]
Yao Xue Xue Bao. 2007 Oct;42(10):1023-8.
7
Prediction of cytochrome P450-mediated drug clearance in humans based on the measured activities of selected CYPs.基于选定 CYP 酶的实测活性预测人体细胞色素 P450 介导的药物清除率。
Biosci Rep. 2017 Nov 21;37(6). doi: 10.1042/BSR20171161. Print 2017 Dec 22.
8
[Relationship between nutritional status and drug metabolism in man].[人体营养状况与药物代谢之间的关系]
Pol Tyg Lek. 1978 Aug 28;33(35):1387-90.
9
In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance.人药物葡萄糖醛酸化的体外分析及体内代谢清除率的预测
J Pharmacol Exp Ther. 2002 Apr;301(1):382-90. doi: 10.1124/jpet.301.1.382.
10
Toward an integrated human clearance prediction strategy that minimizes animal use.迈向一种将动物使用量降至最低的综合人体清除率预测策略。
J Pharm Sci. 2011 Oct;100(10):4518-35. doi: 10.1002/jps.22635. Epub 2011 Jun 24.

引用本文的文献

1
Evaluation of drug-drug interaction potentials between JP-1366 and celecoxib using physiologically based pharmacokinetic modeling.使用基于生理的药代动力学模型评估 JP-1366 与塞来昔布之间的药物相互作用潜力。
Transl Clin Pharmacol. 2025 Jun;33(2):90-99. doi: 10.12793/tcp.2025.33.e10. Epub 2025 Jun 27.
2
Optimization of Tambjamines Active against Multiple Stages of Malaria Parasites.对疟原虫多个阶段有效的坦布连胺类化合物的优化
J Med Chem. 2025 Jun 12;68(11):11746-11785. doi: 10.1021/acs.jmedchem.5c00597. Epub 2025 Jun 1.
3
Evaluation of Violacein Metabolic Stability and Metabolite Identification in Human, Mouse, and Rat Liver Microsomes.
紫菌素在人、小鼠和大鼠肝微粒体中的代谢稳定性评估及代谢物鉴定
Pharmaceutics. 2025 May 2;17(5):601. doi: 10.3390/pharmaceutics17050601.
4
Development of Next-Generation Antimalarial Acridones with Radical Cure Potential.具有根治潜力的下一代抗疟吖啶酮的研发。
J Med Chem. 2025 Apr 24;68(8):8817-8840. doi: 10.1021/acs.jmedchem.5c00419. Epub 2025 Apr 3.
5
Structure-activity relationship studies and pharmacological evaluation of 4-phenylthiazoles as dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors.4-苯基噻唑作为双溶性环氧化物水解酶/脂肪酸酰胺水解酶抑制剂的构效关系研究及药理学评价
Bioorg Med Chem. 2025 Apr 15;121:118112. doi: 10.1016/j.bmc.2025.118112. Epub 2025 Feb 17.
6
Oxazole-Based Ferroptosis Inhibitors with Promising Properties to Treat Central Nervous System Diseases.具有治疗中枢神经系统疾病潜力的基于恶唑的铁死亡抑制剂。
J Med Chem. 2025 Feb 27;68(4):4908-4928. doi: 10.1021/acs.jmedchem.4c03149. Epub 2025 Feb 6.
7
An Ultra-Fast Validated Green UPLC-MS/MS Approach for Assessing Revumenib in Human Liver Microsomes: In Vitro Absorption, Distribution, Metabolism, and Excretion and Metabolic Stability Evaluation.一种用于评估人肝微粒体中瑞武尼布的超快速验证绿色超高效液相色谱-串联质谱法：体外吸收、分布、代谢、排泄及代谢稳定性评估
Medicina (Kaunas). 2024 Nov 21;60(12):1914. doi: 10.3390/medicina60121914.
8
Liver organoids: Current advances and future applications for hepatology.肝脏类器官：肝脏学的当前进展与未来应用
Clin Mol Hepatol. 2025 Feb;31(Suppl):S327-S348. doi: 10.3350/cmh.2024.1040. Epub 2024 Dec 26.
9
Prioritization of Eleven-Nineteen-Leukemia Inhibitors as Orally Available Drug Candidates for Acute Myeloid Leukemia.优先考虑十一-十九-白血病抑制剂作为口服药物候选物治疗急性髓系白血病。
J Med Chem. 2024 Nov 28;67(22):20100-20117. doi: 10.1021/acs.jmedchem.4c01337. Epub 2024 Nov 12.
10
An Ultra-Fast Green UHPLC-MS/MS Method for Assessing the In Vitro Metabolic Stability of Dovitinib: In Silico Study for Absorption, Distribution, Metabolism, Excretion, Metabolic Lability, and DEREK Alerts.一种用于评估多韦替尼体外代谢稳定性的超快绿色 UHPLC-MS/MS 方法：吸收、分布、代谢、排泄、代谢不稳定性和 DEREK 警报的计算机预测研究。
Medicina (Kaunas). 2024 Oct 4;60(10):1626. doi: 10.3390/medicina60101626.